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Abstract In recent years, technical advances and improve-
ments in cardiac computed tomography (CT) and cardiac
magnetic resonance imaging (MRI) have provoked increas-
ing interest in the potential clinical role of these techniques
in the non-invasive work-up of patients with suspected
coronary artery disease (CAD) and correct patient selection
for these emerging imaging techniques. In the primary
detection or exclusion of significant CAD, e.g. in the
patient with unspecific thoracic complaints, and also in
patients with known CAD or advanced stages of CAD, both
CT and MRI yield specific advantages. In this review, the
major aspects of non-invasive MR and CT imaging in the
diagnosis of CAD will be discussed. The first part describes
the clinical value of contrast-enhanced non-invasive CT
coronary angiography (CTCA), including the diagnostic
accuracy of CTCA for the exclusion or detection of
significant CAD with coronary artery stenoses that may
require angioplastic intervention, as well as potentially
valuable information on the coronary artery vessel wall. In
the second section, the potential of CT for the imaging of
myocardial viability and perfusion will be highlighted. In
the third and final part, the range of applications of cardiac
MRI in CAD patients will be outlined.
Keywords Coronary artery disease.Diagnosis.CT.MRI
Introduction
In recent years, technical advances and improvements in
cardiac computed tomography (CT) and cardiac magnetic
resonance imaging (MRI) have provoked increasing interest
in the potential clinical role of these techniques in the non-
invasive work-up of patients with suspected coronary artery
disease (CAD) and correct patient selection for these
emerging imaging techniques. In the primary detection or
exclusion of significant CAD, e.g. in the patient with
unspecific thoracic complaints, and also in patients with
known CAD or advanced stages of CAD, both CTand MRI
yield specific advantages.
Most established non-invasive diagnostic techniques in
the primary diagnostic work-up of patients with suspected
CAD, such as stress electrocardiography (ECG), stress
echocardiography or scintigraphy [single photon emission
computed tomography (SPECT) and positron emission
tomography (PET)] are aimed at the detection of a reduced
coronary perfusion reserve, i.e. detection of reduced
myocardial perfusion or regional wall motion abnormalities
under stress conditions. In recent years, MRI and CT have
also increasingly been used in the primary diagnostic work-
up of CAD. Such primary diagnosis of CAD by MRI and/
or CT can utilise different strategies: detection of coronary
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DOI 10.1007/s13244-010-0049-0calcifications; imaging coronary artery stenoses; and detec-
tion of a reduced coronary perfusion reserve (resulting in
restricted myocardial perfusion with or without impairment
of myocardial function). For these indications, CT and MRI
applications available are:
1. Coronary calcification scoring (or coronary vessel wall
imaging in general) by CT
2. Non-invasive coronary angiography by MRI or CT
3. Stress cine MRI and stress perfusion MRI
4. Myocardial viability imaging using MRI or CT
Recently, the first results of stress perfusion CT have
also been published. Many of these imaging methods have
been reported to yield a high negative predictive value, i.e.
a normal result of these tests rules out a haemodynamically
significant CAD with a high probability. For a reasonable
implication of imaging strategies in clinical practice,
however, the pre-test probability must be considered to
avoid needless examinations [1]. High pre-test probability
invariably demands invasive coronary angiography for
planning or performing revascularisation therapy. Interme-
diate pre-test probability, on the contrary, justifies deferring
further imaging studies, if MRI and/or CT are/is normal.
Cardiac MRI has matured into a multipurpose non-
invasive imaging tool for the assessment of ischaemic
cardiomyopathy. The breadth of applications possible with
cardiac MRI allows combined non-invasive assessment of
myocardial perfusion, function and myocardial viability—a
task that usually requires use of myocardial scintigraphy
and echocardiography. As such, cardiac MRI currently
holds a strong position in the non-invasive work-up of
patients with CAD. The distinct advantages of MRI over
current conventional nuclear-based cardiac-imaging techni-
ques, such as PET or myocardial scintigraphy, include its
high spatial resolution and lack of exposure of the patient to
ionising radiation. Also, quantification of cardiac morphol-
ogy and function by MRI is more accurate and image
quality is more reproducible than in echocardiography,
independent of the operator’s experience and skill level or
the patient’s anatomy.
On the other hand, the technical parameters of cardiac
CT, such as the temporal and spatial resolution, have shown
a dramatic improvement over the last few years. Today’s
system generations reach a spatial resolution of up to
0.5 mm, with a temporal resolution of less than 50 ms and
imaging times of less than 1 s, depending on the CT
systems used. With an increasing number of cases
permitting excellent visualisation of both coronary artery
lumen and wall, and based on many publications suggest-
ing high sensitivities and specificities for the detection or
exclusion of significant coronary stenosis, CT coronary
angiography (CTCA) is being adopted into clinical practice
more and more frequently. However, imaging of myocardial
viability and quantification of myocardial perfusion with
CT has not yet become a clinical reality, even if these
applications would greatly complement non-invasive
coronary CT angiography.
The review and outlook presented here will focus on
three major aspects of non-invasive MR and CT imaging in
the diagnosis of CAD. The first part describes the clinical
value of contrast-enhanced non-invasive CT coronary
angiography, including the diagnostic accuracy of CT
coronary angiography for the exclusion or detection of
significant CAD with coronary artery stenoses that may
require angioplastic intervention, as well as potentially
valuable information on the coronary artery vessel wall. In
the second section, the potential of CT for imaging of
myocardial viability and perfusion will be highlighted. In
the third and final part, the range of applications of cardiac
MRI in CAD patients will be outlined. Not all the imaging
methods described in this review are already being used in
the daily clinical work-up of patients with CAD, but they
are being used more and more every day. Therefore, their
correct clinical indication and clinical value need to be
discussed.
CT coronary angiography: luminography and beyond
CT coronary angiography: are we there yet?
Coronary catheter angiography (CCA) is still considered to
be the clinical standard technique for the evaluation of
CAD. However, the risk of serious complications associat-
ed with CCA is not negligible, and inconvenience for the
patient and economic deliberations have strengthened the
search for a non-invasive alternative. Currently, CT is the
most promising imaging technique for the non-invasive
evaluation of the coronary artery tree. Current CT technol-
ogy combines high spatial and temporal resolution with fast
volume coverage, thus enabling imaging of the small and
fast-moving coronary arteries within a single breath-hold.
A huge number of publications have abounded evaluat-
ing the diagnostic performance of CT coronary angiogra-
phy. With continuous development in CT system
generations—starting with four-slice CT until the advent
of the most recent 320-slice and second-generation dual-
source CT systems—the diagnostic accuracy performs as
follows [2]. Patients with significant morphological coro-
nary stenoses are detected with a sensitivity of 95% or
higher. With modern technology, the specificity to detect
patients with significant morphological coronary artery
stenoses with CT showed steady improvement. In parallel,
the number of segments showing a non-diagnostic image
quality decreased. Most importantly, the negative predictive
value of CT coronary angiography has been reported in
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excellent ability of this non-invasive imaging technique to
rule out significant morphological CAD (Fig. 1).
The most important clinical indication for CT coronary
angiography is the evaluation of chest pain syndrome in
patients with intermediate pre-test probability of CAD and
uninterpretable ECG, or the inability of the patient to
undergo exercise testing [3]. On the other hand, patients
with a high pre-test probability of CAD should not
undergo CT coronary angiography. Similarly, in patients
with a low pre-test probability, the appropriateness of CT
coronary angiography is considered uncertain. In a clinical
context, CT should be used as a filter test: When the CT
coronary angiography test results are negative, no further
invasive work-up is required, and when the results are
positive, CCA should subsequently be performed in most
cases.
Despite these performance characteristics, CT is associ-
ated with a number of shortcomings. First, elevated and
irregular heart rates still pose a challenge for CT coronary
angiography. Although this challenge has been partly
overcome with most recent CT systems having a very high
temporal resolution of up to 43 ms, a decrease in image
quality is still present in patients with combined high and
irregular heart rates. Another limitation is represented by
severe calcifications in the arterial vessel walls, causing so-
called blooming artefacts. This hinders the evaluation of the
coronary artery lumen, eventually causing an overestima-
tion of the degree of stenoses (and thus, a false-positive CT
result). Finally, an important draw-back of CT is the
radiation exposure associated with the technique [4]. With
earlier CT generations, effective radiation doses of >20 mSv
have been reported. In the meantime, however, various
radiation dose-saving algorithms have been developed [5]
that all prove efficient in the reduction of the radiation
exposure, to a dose that is similar or below that reported for
CCA. Two of these radiation dose-saving techniques should
be mentioned briefly:
First, prospectively ECG-gated CT coronary angiogra-
phy, also called the “step-and-shoot” mode, has been
introduced. This mode is characterised by turning on the
X-ray tube only at a predefined time point of the cardiac
cycle, usually in mid-diastole, while keeping the patient
table stationary. The X-ray exposure time of this technique
is short, and thus, low radiation doses, ranging between 1.2
and 4.3 mSv, have been reported using various 64-slice and
first-generation dual-source 64-slice CT systems [6–8].
Most importantly, this low-dose CT coronary angiography
technique was still accurate in the diagnosis of coronary
artery stenoses [9].
Second, along with the introduction of the recent second-
generation dual-source CT, the high-pitch mode has been
introduced for cardiac CT [10–13]. In this mode, data
acquisition is also prospectively triggered with the ECG of
the patient. However, the data are acquired in a spiral mode,
with the CT table running with a very high pitch of 3.4.
Using this high-pitch mode, the entire heart can undergo
imaging within only one single diastole. Various reports
have indicated that this technique delivers not only a low-
radiation dose of around or below 1 mSv for a cardiac
study, but also showed that this mode provides diagnostic
image quality [10–13]. Similar to the step-and-shoot mode,
the high-pitch mode is also characterised by high diagnostic
performance [14].
Fig. 1 CT coronary angiogra-
phy in a 55-year-old male
patient with atypical chest pain
demonstrating normal coronary
arteries. a Right coronary artery
(RCA); b left anterior
descending coronary artery
(LAD), c left circumflex
coronary artery (LCX), with no
plaques or stenoses. In this
patient, CT reliably ruled-out
CAD; no subsequent invasive
catheter coronary angiography is
required
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The imaging reference standard for the detection and
characterisation of coronary artery plaques in patients is
intravascular ultrasound (IVUS). Owing to its excellent
spatial and contrast resolution, IVUS is able to characterise
and classify coronary artery plaques with a high accuracy
compared with histopathology. However, IVUS is an
invasive technique and thus not feasible in asymptomatic
patients, i.e. in a preclinical setting. Thus, a non-invasive
imaging test with the ability to characterise and quantify
features of an individual coronary artery plaque and the
overall coronary atherosclerotic plaque burden could have a
tremendous effect on the prevention and treatment of CAD
[15].
The advantage of CT coronary angiography—beyond its
ability to image the degree of luminal stenosis—is the
simultaneous detection and characterisation of coronary
atherosclerotic plaques. In contrast-enhanced CT coronary
angiography, imaging of calcified, mixed and non-calcified
coronary plaques is possible (Fig. 2). Thus, research
targeting the qualitative and quantitative assessment of
coronary plaques, including the assessment of plaque size,
plaque composition and plaque remodelling, has become
feasible. Importantly, the relevance of plaque detection and
quantification by CT derives from its independent prog-
nostic value in patients with known or suspected CAD [16,
17]. It is important to note that the normal coronary wall
cannot be assessed by CT because of inherent limitations in
spatial resolution. However, plaques of potential clinical
importance tend to be larger, having a sizeable necrotic
core, and are most often found in the proximal coronary
arterial segments. This makes them accessible for visual-
isation with CT [15].
With 64-slice CT, a sensitivity of 83% was found for
detecting non-calcified coronary artery plaques. Regarding
calcified plaques, a higher sensitivity of 95% was demon-
strated [18]. Comparable results were reported by other
groups employing 64-slice CT [15], indicating a still
suboptimal spatial and temporal as well as contrast resolu-
tion of CT. Importantly, observer experience also has a
significant impact on the accuracy of plaque detection [19].
Regarding the quantification of coronary arterial plaque
volume with CT, correlations are only moderate compared
with IVUS. In general, the accuracy varies with coronary
arterial plaque composition: volumes of non-calcified and
often also mixed plaques are frequently underestimated,
whereas the volume of calcified plaque is often over-
estimated in CT [20]. The latter can be explained by
blooming artefacts and by partial volume effects caused by
the contrast-enhanced vessel lumen. Finally, standardised
and software-based automated assessment of coronary
plaques with CT is still lacking [21]. Quantitative coronary
artery plaque composition has been repetitively assessed
with various CT generations [22, 23]. Most investigators
measured CT numbers (in Hounsfield units) to determine
the ability of CT to characterise and to distinguish the
various plaque types. However, although early study results
were promising, studies have consistently shown that CT
numbers of non-calcified plaque components vary widely.
Although mean values were often significantly different
between fibrous and lipid-rich coronary arterial plaques, a
substantial overlap of CT numbers was found, precluding a
reliable characterisation and differentiation of the various
Fig. 2 CTCA demonstrating a
non-calcified (a), a mixed (b),
and a calcified (c) coronary
arterial plaque
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measurements of CT numbers in coronary plaques should
be made with caution, because contrast enhancement within
the vessel lumen considerably affects attenuation measure-
ments of the plaques in the adjacent vessel wall [24]. Also,
the use of different tissue reconstruction filters affects the
CT numbers of coronary arterial plaques [25].
Future directions of CT for plaque detection and
characterisation include a more detailed morphological
analysis of coronary plaque types [26], and eventually the
use of molecular imaging in adjunct with contrast agents
targeting specific cells that are important in the develop-
ment and evolution of coronary arterial plaques [27].
CT viability und perfusion
Assessment of myocardial viability and myocardial perfu-
sion plays a critical role in the evaluation of patients with
CAD as patterns of myocardial perfusion are associated
with short- and long-term prognosis and the haemodynamic
relevance of a coronary artery stenosis [28, 29]. Cardiac
CT, which has evolved as a useful tool for the assessment
of obstructive and non-obstructive plaque, has mainly been
limited to the morphological assessment of CAD, i.e. CT
coronary angiography [30]. However, imaging of myocar-
dial viability and quantification of myocardial perfusion
would greatly complement non-invasive coronary CT
angiography. Within recent years, a number of studies have
focused on the demonstration of myocardial "perfusion"
deficits using multidetector (MD) CT. However, most of the
studies used either a single volume data acquisition during
the angiographic phase or double exposure with the
acquisition of an additional delayed phase data set.
However, this approach is based on static imaging rather
than on dynamic imaging. Therefore, these kinds of
datasets represent more a kind of blood volume distribution
(early phase) and a delayed contrast agent distribution, i.e.
an approach similar to delayed imaging in MRI [31, 32].
This delayed imaging focuses on the visualisation of
myocardial viability, a technique that is commonly used in
MRI and has already been reported on in the early days of
CT imaging [33, 34]. “Real” myocardial perfusion imaging
with CT techniques would be based on the dynamic
visualisation of a contrast agent during its first pass through
the cardiac chambers, coronary arteries and myocardium.
Within the last decade, the approach of dynamic, i.e. time-
resolved, first-pass perfusion imaging has already been
extensively evaluated using dynamic contrast-enhanced
MRI. It has been shown that the combination of rest and
stress studies even allows the calculation of the myocardial
perfusion reserve and allows reliable assessment of haemo-
dynamic significant vessel changes [35]. However, while in
MRI the linearity of the contrast agent concentration and
the signal intensity is limited to a certain range of
concentrations of the contrast agent and varies with
sequence parameter changes, CT techniques would offer a
major benefit addressing this issue: they provide constant
linearity of contrast concentration and density.
CT viability imaging
Acute ischaemic changes in the myocardium after coronary
arterial occlusion consist of disruption of cell membrane
function and integrity and increased permeability of small
vessel walls. In contrast-enhanced CT coronary angiogra-
phy, the area of low attenuation within the myocardium
primarily reflects myocardial oedema, i.e. a pronounced
water content of the myocardium, followed by infiltration
of inflammatory cells. Subsequently, over days and weeks,
necrotic myocardium is replaced by fibrous and/or fatty
tissue, which is also characterised by a reduction of
attenuation in CT in a CTCA, compared with normal
myocardium [36, 37]. A number of initial reports on the
application of CT in patients with myocardial infarction have
been promising, including early animal studies [38–40]a n d
experiences with electron beam (EB) CT [41–43]. With the
introduction of multislice CT systems, myocardial viability
imaging using CT has experienced renewed interest, with
several early case reports showing the capability of the
technique to detect myocardial infarctions [44, 45]. In
general, one has to distinguish two major acquisition
techniques that have been reported using CT for the
depiction of myocardial viability: (1) the “typical” CTCA,
i.e. an arterial first-pass image of the myocardium, without
requiring any additional contrast agent or radiation dose; (2)
a dedicated CT late enhancement technique, which would
typically be added to a CT coronary angiogram as a second
imaging procedure, and thus, requiring additional radiation
dose (and typically more contrast agent than CTCA alone).
With the first protocol, i.e. in the arterial first-pass phase
after contrast agent injection, a myocardial infarct area is
typically detectable as a perfusion defect, i.e. hypodensity
of the myocardium, as explained above (Figs. 3 and 4).
Such a myocardial hypodensity in the first-pass arterial
phase image, however, is not specific to infarctions, as
similar findings can occur in cases with severe local
ischaemia (but no infarction) or other cardiac diseases
causing perfusion heterogeneities, such as hypertrophic
cardiomyopathy. Also, myocardial contrast enhancement
depends on a number of independent variables, e.g. the
contrast agent injection protocol or the cardiac output. That
is why a significant variance of measured CT attenuation
[Hounsfield units (HU)] can be observed in normal and
infarcted myocardium in the arterial first pass, indicating
that no absolute HU values can be defined, but the relative
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factor [37]. Wall thinning of the left ventricular myocardi-
um is one of the indirect findings associated with the
healing process after myocardial infarction, caused by
scarring. When it comes to the exact sizing of myocardial
infarctions during the arterial first pass of the contrast
agent, several studies have reported that CT underestimates
the true extent of a myocardial infarction [37, 41]. This
might be related to patchy and subendocardial infarctions,
as collateral perfusion in the area of infarcted myocardium
can obscure foci of necrosis surrounded by normal
myocardium. In conclusion, one should interpret infarct
size as assessed by contrast-enhanced, arterial phase MDCT
as an approximation to the true infarct size rather than as an
absolute measurement.
With the second protocol, i.e. a dedicated CT protocol
for “delayed contrast enhancement”, a second imaging
procedure is added to the CTCA protocol. Typically, this
second procedure is performed 10-20 min after the first
injection of contrast agent. The infarct zone will then be
depicted as a hyperdense area, with increased uptake of the
contrast agent, compared with the normal myocardium.
This is because the contrast agent accumulates in the
necrotic tissue (as also known from delayed enhancement
MRI techniques) [46]. For optimal results of CT late
enhancement imaging in myocardial infarctions, the applied
Fig. 3 A 61-year-old male patient with acute myocardial ischaemia
and corresponding myocardial perfusion defect from a 85% coronary
stenosis in the left circumflex coronary artery (LCX). Imaging on
dual-source CT was performed after percutaneous coronary stent
placement in the LCX (c). a Multiplanar reformat (narrow window)
two-chamber view demonstrating the contrast agent-filled left and
right ventricle and the hypoperfused lateral-inferior wall (arrow) while
the anterior and septal myocardium is homogeneously enhanced. b
Longitudinal view of the left ventricle with the perfusion defect of the
lateral wall consistent with the LCX lesion
Fig. 4 Myocardial infarction and corresponding myocardial perfusion
defect caused by a subtotal occlusion of a left anterior descending
coronary artery (LAD) in a 57-year old female patient with multiple
cardiovascular risk factors. a Longitudinal view of the left ventricle
(multiplanar reformat) demonstrating a large perfusion defect in the
anterior wall that is also depicted in the short-axis view (arrows, b). c
As demonstrated in curved maximum intensity projection, the subtotal
occlusion was located inthe mid LAD segment justdistal to a stent in the
proximal coronary segment, which had been placed 3 months earlier due
to a significant lesion detected on elective invasive angiography
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al. [47] have shown excellent results in animal studies,
using 2 ml per kg body weight or even more. However, this
would increase the required amount of contrast agent in
patients. For a patient of 75 kg, a typical CT coronary
angiogram would be performed with about 60-100 ml of
contrast agent (depending on the CT system generation
used). For an optimised delayed enhancement acquisition,
the optimal amount of contrast agent would be higher, e.g.
within the range of 100-150 ml. In general, the late
enhancement effect was primarily found in recent infarc-
tions, but also reported to be detectable in chronic
infarctions [47]. Habis et al. [48] could show perfect results
by immediately injecting contrast agent via the coronary
angiography catheter that was placed in the culprit coronary
artery early after an acute myocardial infarction. Attempts
to further optimise the CT late enhancement technique
include usage of lower tube voltages [49], or reconstruction
of thicker slices to be able to reduce radiation dose and still
maintain a sufficiently high contrast-to-noise ratio. Even
with these adaptations, so far, the detection of myocardial
delayed enhancement still requires additional imaging
procedures with an increased application of radiation dose
to the patient and prolonged examination times, and it is
therefore not being used extensively in clinical routine
today. On the other hand, a comprehensive CT protocol
including CTCA, display of myocardial perfusion defects
and potentially myocardial viability and function would be
a highly desirable application in CAD patients [50].
Therefore, it seems very probable that future studies on
CT viability imaging will further enhance this technique
and make it applicable in clinical routine, e.g. even using
unenhanced CT techniques, as published recently [51].
CT perfusion imaging
The potential of CT to quantify myocardial perfusion using
a “real” perfusion technique, i.e. a repeated, time-resolved,
dynamic CT during myocardial wash-in and wash-out of
the contrast agent, was already recognised in the 1980s and
1990s using electron beam computed tomography (EBCT).
In animal models and healthy volunteers, early studies
indicated the general ability of EBCT to determine blood
flow and the effect of adenosine by using indicator dilution
methods [52, 53]. Results from Lerman et al. [54]
suggested that EBCT allowed the haemodynamic effect of
a variety of vasoactive agents to be determined. More
recently, Daghini et al. [55] and George et al. [56] showed
similar results for 64-slice CT in an animal study.
Up to now, the technical challenges of time-resolved CT
myocardial perfusion imaging have been substantial. A
long acquisition time, i.e. a long temporal coverage of the
myocardial contrast passage, has to be ensured, resulting in
a mandatory imaging time of approximately 30-40 s. High
temporal resolution is required for (semi-)quantification of
perfusion data, and therefore, the interval between imaging
at identical positions should not exceed one or two
heartbeats. While with earlier CT generations (e.g. 64-
slice CT) the anatomical coverage was limited to the
detector width of a given CT system (typically around
4 cm coverage for 64-slice CT), and thus, only parts of the
myocardium could be covered in a dynamic fashion, recent
technical developments have changed this paradigm. Today,
there are two technical options to cover the whole
myocardium for dynamic perfusion imaging. First, CT with
wide detectors, e.g. 256- or 320-slice CT, covering up to
16 cm without table movement [57], or second, the latest
generation of dual-source CT systems, enabling a so-called
“shuttle mode”, which enables the composition of two
adjacent slabs of myocardium of 4 cm each, resulting in
nearly 8 cm of myocardial coverage in a dynamic fashion
[58]. Overall, a perfusion sequence on MDCT is compara-
ble to an ECG-triggered test bolus technique. To obtain a
reasonable signal-time curve with a modest amount of
contrast agent, high speed injections with a saline flush
technique are preferable to acquire good quality signal-time
curves (e.g. ∼40-50 ml of contrast agent injected at a flow
rate of about 5-8 ml/s).
While all previous efforts at CT myocardial perfusion
imaging were ROI-based, i.e. measuring the time-density
curves in a small portion of the myocardium defined by a
region-of-interest (ROI), a recent study extended these
principles into a quantitative three-dimensional (3D) imag-
ing technique, permitting regional myocardial blood flow
(MBF) to be derived in patients in combination with CT-
based morphological assessment of CAD, i.e. CTCA.
Furthermore, using a second-generation dual-source CT,
this study by Bamberg et al. [58] was the first to combine
sufficient anatomical coverage, i.e. the whole myocardium,
with a sufficiently high temporal resolution and stability of
HU values, testing for stress-induced hypoperfusion in
patients with known CAD (Fig. 5).
There are many technical aspects that need further
optimisation in cardiac CT perfusion imaging. Even if
modern techniques for reduction of radiation exposure are
applied, the study protocol reported in the study by
Bamberg et al. [58] still resulted in a comparably high total
radiation exposure of an approximately 12-mSv-equivalent
radiation dose (including the perfusion imaging and a
prospective CTCA). On the other hand, this radiation
exposure is similar to that of established retrospective
CTCA examinations on 64-slice CT (with a reported
median of 12 mSv in a large multicentre study [59]) and
comparable with or even lower than nuclear perfusion
imaging, the clinical standard for the assessment of
myocardial perfusion (radiation exposure for stress-only
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but that for 2-day
99mTc sestamibi or
201Tl is 20.0 mSv or
higher [60]). Further technical research will be necessary in
CT myocardial perfusion imaging, to develop strategies to
reduce radiation exposure and determine the impact of heart
rate and different injection protocols on image quality,
diagnostic accuracy and radiation exposure. Further valida-
tion studies in larger patient cohorts need to be carried out
with standardised procedures for CT myocardial perfusion
imaging, to prove the robustness and reproducibility of the
technique. Comparisons using adequate gold standards
(fractional flow reserve, MRI, or SPECT) are warranted to
fully determine the diagnostic accuracy of cardiac CT for
the quantification of myocardial perfusion defects in a
blinded fashion. If confirmed, larger randomised diagnostic
trials will be necessary to determine whether myocardial
perfusion imaging by CT will be beneficial compared with
established options using appropriate clinically relevant
endpoints. Also, to prove the usefulness of a combined CT
approach implementing CTCA with CT myocardial perfu-
sion imaging, information on myocardial viability is of
major importance, to differentiate between hypoperfused
but viable from hypoperfused but necrotic myocardium.
Hence, a third CT acquisition for CT late enhancement
would be mandatory in such a comprehensive CTapproach.
Also, the protocol includes the administration of adenosine, a
short-lasting vasodilator, and continuous ECG monitoring.
Contraindications for adenosine include Wolff–Parkinson–
White(WPW)syndrome,atrioventricular(AV)blockandsick
sinussyndromeaswellasasthma.Besidesthedevelopmentof
dose reduction algorithms and optimised contrast agent
injectionprotocolsfordynamicmyocardialperfusionimaging
by CT, work on dedicated reconstruction algorithms that
optimise the contrast-to-noise ratio (CNR) might help further
reduce radiation exposure.
MRI for CAD: “the one-stop-shop”?
General considerations in cardiac MRI
As emphasised earlier, CAD represents a relatively simple
description of a disease that in fact consists of a complex
array of different sub-entities, especially with regard to the
extent, impact and effect upon the heart and its individual
structures. MRI offers a wide variety of techniques that may
Fig. 5 A 71-year-old male patient who presented with stable chest
pain syndrome and a history of cigarette smoking, hyperlipidaemia
and hypertension. His right (a) and left anterior descending coronary
arteries (b) demonstrate the presence of calcified and non-calcified
plaque in all proximal vessel segments. The middle segment of the
RCA has extensive calcification (arrows). Owing to limited evalu-
ability of the coronary lumen, the presence of significant coronary
artery stenosis could not be ruled out. As part of a research protocol,
the subject underwent dynamic adenosine-mediated stress myocardial
perfusion imaging (100 kV, 175 mAs/rot) over a period of 30 s.
Fusion images of the left ventricle (LV) in long axis (c) and short axis
(d) demonstrate homogeneous myocardial blood flow without any
evidence of stress-induced myocardial hypoperfusion. The measured
myocardial blood flow was approximately 125 ml/min/100 g
16 Insights Imaging (2011) 2:9–24be applied in patients with suspected or known CAD. The
overall and final imaging strategy for the assessment of
CAD and its sequelae, however, has to be chosen based on
the clinical background information and the intended
question for further therapeutic decisions. Although cardiac
MRI has long been considered a possible “one-stop-shop”
imaging technique in CAD, this vision is rather theoretical
than applicable in a clinical routine setting. Imaging
strategies in cardiac MR could be addressed in various
fashions; in the following overview, they will be highlight-
ed according to technical issues as well as important
clinical scenarios.
Assessment of coronary artery stenoses and myocardial
ischaemia
Coronary artery MRI
Direct assessment of the coronary arteries and assessment
of potential coronary artery stenoses are considered the
holy grail of cardiac imaging. Although such an approach
does only assess morphological changes, without any
information on the haemodynamic relevance of a given
stenoses, non-invasive MR coronary angiography has
always been, and still remains, the ultimate goal for cardiac
MRI. Ever since the first promising reports on coronary
MR angiography in the early 1990s, with reported
sensitivities and specificities of about 90% for ≥50%
stenosis [61, 62], numerous technical approaches to
coronary MR angiography have been proposed and
implemented. Although software techniques as well as
hardware have substantially changed, MR has not been able
to either come to reproduce these promising early results, or
to match results from the various generations of MDCT
systems, except in cases with high coronary calcium score
where CTCA may be of limited use [63]. Technical improve-
ments incorporated various data acquisition strategies such
as respiratory-gated coronary MR angiography, i.e. navigator
techniques [64], as well as various strategies of whole heart
coronary MR angiography with respiratory gating (Fig. 6)
[65–68].
Clinical results though have generally not substantially
improved with these technical developments, although
overall imaging time has shortened. A major multi-centre
study on 3D coronary MR angiography (on a single vendor
platform) reported a sensitivity of 93% (in assessable
segments) for any CAD >50%, while the specificity was
as low as 42% [69]. Schuetz et al. [70] recently published a
pooled sensitivity and specificity of coronary MR angiog-
raphy of 87% and 70%, respectively, for the diagnosis of a
≥50% coronary artery stenosis. These data are based on a
meta-analysis incorporating 20 studies on coronary MRA
(989 patients) that have been published from 1999 to
2009. The current superiority of MDCT coronary angiog-
raphy has been demonstrated by a pooled sensitivity of
97% and specificity of 87%, not even focusing on studies
using only the most modern CT techniques and heart rate
control [70].
Regarding the development of coronary MR angiogra-
phy techniques, the following trends have consistently been
reported:
& Three-dimensional steady-state free precession (SSFP)
techniques allow for a higher image quality and CNR
(blood/myocardium) than 3D gradient recalled echo
(GRE) approaches [71, 72]
& The use of gadolinium-based contrast agents (GBCA)
further improve CNR, irrespective of whether extracel-
lular or intravascular compounds have been applied
[68, 73, 74]
The use of higher field-strength (3 Tesla) and/or
dedicated multi-element array coils for signal reception
further pushed coronary MRA and resulted in improved
signal-to-noise ratio (SNR) and CNR values [66, 73, 75].
The latter allows for either the improvement of spatial
resolution or the reduction of imaging time with the use of
Fig. 6 Whole-heart coronary
MRA (with slow Gd-chelate
infusion) in a 24-year-old
patient who had complained
about recurrent chest pain on
exertion since his childhood.
The data set demonstrates a
normal RCA (long arrow) and a
myocardial bridging of the LAD
with a minor bending along its
course (short arrows)
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techniques) [76]. Yang et al. [77] recently were able to
demonstrate a sensitivity of 93% and a specificity of 89%
for >50% stenosis on a per-vessel basis, and 94% and 82%,
respectively, on a per-patient basis. Although not yet
implemented for all coronary MR angiography studies, the
use of pharmacological patient preparation for heart rate
control (e.g. beta-blocker) or coronary vessel diameter (e.g.
nitroglycerine) is increasingly being used and does show
benefits in image quality [78, 79].
Taking into account all imaging preparation and scouting/
localising procedures, coronary MR angiography still
remains a time-consuming and labour-intensive method.
Although its useful application in a CAD population is still
questionable, the technique may already today be routinely
applied in the evaluation of proximal coronary artery
anomalies, a possible cause of sudden coronary death in
young athletes [80].
Myocardial perfusion imaging
Besides the direct visualisation of coronary artery stenosis,
the indirect assessment of possible underlying stenotic
CAD can also be rendered by MRI, using myocardial
perfusion imaging. Rather than imaging of a coronary
stenosis, this approach focuses on the assessment of a
possible haemodynamic impact of a coronary artery lumen
reduction on the downstream myocardial blood supply.
First-pass myocardial perfusion imaging is based on the
use of gadolinium-based contrast agents (GBCA) as a
tracer, and fast T1-weighted gradient recalled echo (GRE)
or echoplanar imaging (EPI) hybrid techniques [81]. Rapid
update imaging with a single-heart-beat resolution is
required and allows for tracing of an extracellular contrast
agent passing through the right ventricle (RV), the left
ventricle (LV) and the myocardium. Regarding the assess-
ment of the potential haemodynamic significance of a given
coronary artery stenosis though, the use of proper stress
testing is necessary in combination with myocardial
perfusion imaging, as coronary luminal changes may
compensate for a wide range of coronary luminal changes
and therefore mask the presence of even high-grade lesions
[82, 84]. While dipyridamole and adenosine are at present
most commonly used for vasodilation and thereby induce
stress while performing MR myocardial perfusion imaging,
newer vasodilators with more selective mechanisms may
shortly be available that would ease the use in asthmatic
patients or patients with chronic obstructive pulmonary
disease (COPD) [83, 84].
The general principle of first-pass MR myocardial
perfusion imaging has been evaluated by Wilke et al. [85,
86], as well as by other research groups, and has mainly
been based on animal models that allow for comparison
with reference standards (e.g. microspheres). Although the
technique would in theory allow for a quantitative
assessment of myocardial perfusion, the complex work-up
of the MRI data and the lack of standardised post-
processing methods for perfusion quantification still pre-
vent the technique from being used in a clinical workflow.
Hence, most centres still rely on the visual interpretation of
perfusion data sets (Fig. 7). In a recent meta-analysis, stress
myocardial perfusion imaging has been reported with a
Fig. 7 Combined stress (upper
row) and rest (lower row)
first-pass myocardial perfusion
imaging (0.5 mmol/kg BW)
demonstrating a reversible
subendocardial perfusion deficit
(arrows) in the inferioseptal and
inferior aspect of the LV
myocardium
18 Insights Imaging (2011) 2:9–24pooled sensitivity and specificity of 91% and 81%, including
studies with qualitative and quantitative approaches for the
detection of a ≥50% diameter stenosis [87]. The benefit of
quantitative analysis, though, has most recently been pointed
out again by Patel et al. [88], and especially holds true for
triple-vessel disease patients. Possible discrepancies of MR
perfusion imaging with regard to standards such as quanti-
tative coronary angiography (QCA) may not be related to the
technical shortcomings of either imaging technique, but to
the limitations of QCA in the assessment of the haemody-
namic significance of a stenosis. While first-pass myocardial
perfusion imaging evaluates functional aspects, QCA dem-
onstrates morphological features, but delivers no functional
information. Schwitter et al. [89] have demonstrated a higher
sensitivity and specificity of first-pass perfusion imaging in
comparison with PET definitions of ischaemia (91% and
94%, respectively) compared with the QCA diagnosis of
>50% coronary artery stenosis (87% and 85%, respectively).
The limited accuracy of QCA in the assessment of the
haemodynamic severity of a given stenosis, especially in
intermediate lesions, has been pointed out repeatedly
[90, 91]. Regarding MR myocardial perfusion, most recent
studies in fact focused on the use of invasive fractional
flow reserve (FFR) measurements, serving as the standard
of reference [92–94] .U s i n ga nF F Ro f< 0 . 7 5a sac u t - o f f
value for the differentiation of haemodynamic significant
versus non-significant lesions, first-pass MR perfusion
imaging showed a sensitivity and specificity of 91% and
94% [93].
Technical MR developments, such as the advent of
parallel imaging algorithms or the ongoing widespread use
of higher magnetic field strength certainly has an impact on
first-pass myocardial perfusion imaging [95, 96]. Owing to
the shortening of data acquisition intervals in the cardiac
cycle using multiple element receiver-coils and parallel
imaging algorithms, the frequency and severity of dark rim
artefacts can be reduced, and as such, false-positive results
may be potentially reduced [95]. The use of 3-Tesla field
strength has not only been shown to provide benefits with
regard to SNR, CNR and the amplitude of the SI-time
curve but also, and more importantly, a potential impact on
the accuracy of first-pass myocardial perfusion results
[96–99]. Cheng et al. [98]r e p o r t e da ni n c r e a s eo f8 2 %t o
90% and 90% to 98% for sensitivity and specificity,
respectively, when moving from 1.5 to 3 Tesla in an intra-
individual comparative study of MR stress perfusion
imaging for the detection of significant coronary artery
lesions.
On the other hand, also at 3 Tesla, imaging parameters
need to be well balanced with regard to spatial resolution,
SNR and data acquisition time windows, to provide optimal
results without interfering artefacts [100]. Also, the volume
of injected contrast agent has to be considered and adapted;
as for a visual assessment, a higher dose of contrast agent is
typically recommended than for a quantitative assessment.
The approach of a dual bolus setting though may allow
both analyses in the same setting [88, 101].
New imaging approaches under investigation for the
assessment of myocardial perfusion include techniques
such as blood oxygen level-dependent (BOLD) techniques
that potentially allow for detection of the effects of regional
variations in myocardial blood flow based on the intrinsic
contrast mechanism of desoxyhaemoglobin. Studies have
demonstrated a good correlation with reference standards,
and again, the use of a higher magnetic field strength (e.g. 3
Tesla) shows promise for further improvements in BOLD
imaging [102–104].
Stress cine MRI
While MR perfusion imaging focuses on the direct
detection of ischaemia at the myocardial blood supply
level, stress cine imaging provides an indirect approach to
visualising the potential impact of hypoperfusion and thus
impaired myocardial oxygen supply on wall motion [105].
The underlying principle is not different from stress
echocardiography and according to the guidelines of the
major societies, high-dose protocols with infusion rates of
10, 20, 30 μg/kg/min up to a maximal dose of 40 μg/kg/min
were adopted for dobutamine stress cine MRI (with the
possible additional use of atropine). Other than vaso-
dilators, used for stress perfusion MRI, stress cine MRI is
based on the use of dobutamine, with a positive inotropic
and chronotropic effect. This leads to a more “physiolog-
ical stress” and allows for a better definition of peak stress
levels compared with “stress” induced by vasodilators
[105].
Typical MRI techniques for dobutamine stress imaging
are based on standard functional techniques such as cine
SSFP. The application of dobutamine stress in the MR
environment though necessitates close patient monitoring
with adequate, MR-compatible equipment. At different
stress levels, cine MR images are being acquired and
screened for newly developed wall motion abnormalities as
a marker of insufficient myocardial oxygen supply. Nagel et
al. [106] reported a sensitivity and specificity of 86% and
86% for diagnosis of ≥50% stenosis. The improved results
compared with stress echocardiography in this study,
though, were mainly based on the fact that MRI performs
better than echocardiography in patients with poor acoustic
windows. The results of this study are in good concordance
with pooled data from a recent meta-analysis. Based on 14
studies applying stress cine MRI (mainly dobutamine use),
Nandalur et al. [87] evaluated an overall sensitivity of 83%
with a specificity of 86%, for the detection of significant
CAD.
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Total or temporary occlusion of a coronary artery may
result in temporary ischaemic damage or myocardial death
and necrosis in the downstream coronary artery territory.
The extent of myocardial death in the setting of myocardial
infarction has a substantial impact on the outcome of the
patient. Myocardial infarction and its sequelae not only
show a major impact on cardiac function and possible
subsequent cardiac failure, but also on the risk of inducing
severe arrhythmias.
MRI of myocardial viability has substantially changed
over the last two decades. The evaluation of late gadolin-
ium enhancement (LGE) techniques has pushed the
envelope for the clinical routine assessment of myocardial
viability using MR techniques. Before the use of LGE
imaging assessment of myocardial viability using MR
approaches has been based on low-dose (5-10 μg/kg/min)
dobutamine stress cine MRI [107, 108]. Early studies by
Kim et al. [109, 110] evaluated the correlation of LGE of
the myocardium and the presence of myocardial viability
and necrosis in animal models. In early patient studies, the
impact of this imaging technique on the prediction of
patient outcome after myocardial infarction and revascular-
isation procedures has been demonstrated [111, 112]. LGE
imaging offers the ability to assess the transmural extent of
residual viability in patients after myocardial infarction. As
a major pre-requisite in the use of LGE techniques in
myocardial ischaemia, it has to be considered that the
extent of myocardial infarction is typically related to
coronary artery supply territories and that the development
of necrosis starts at the subendocardial level propagating
towards the epicardial border over time (Fig. 8)[ 113].
Sequence techniques for assessment of LGE are typical-
ly based on inversion recovery (IR) T1-weighted gradient
recalled echo (GRE) techniques, with additional nulling
[optimisation of inversion times (TI)] of the normal
myocardium [114]. This approach allows for high differ-
ences in signal intensity of viable versus non-viable
myocardium. With ongoing technical developments,
changes in imaging approaches have been proposed and
incorporated into clinical viability imaging. As segmented
data acquisitions in MR rely on constant heart rates and
patient cooperation with consistent breath-holding, image
quality is substantially reduced in patients with severe
arrhythmia or non-cooperative patients. Huber et al. [115]
evaluated the use of single-shot LGE imaging techniques in
combination with SSFP read-out in patients with myocar-
dial infarctions and demonstrated excellent correlation of
infarct size and volume compared with standard segmented
IR techniques. In addition to the elimination of breathing
artefacts, this technique can also be used for a substantial
shortening of MRI time. As the image contrast of standard
LGE imaging techniques relies on optimal TI settings, this
approach is substantially operator-dependent. The use of
advanced image calculation and processing techniques, as
proposed by Kellman et al. [116], has led to the
development of phase-sensitive IR techniques to alleviate
the effects of suboptimal TI settings on overall image
contrast. With regard to the volumetric accuracy of
myocardial infarction this approach has been shown to
demonstrate constant volumes compared with suboptimal
TI settings with changing image contrast [117]. For LGE
imaging, the use of higher magnetic field strength also
demonstrates benefits with regard to signal levels. CNR
levels (viable to non-viable myocardium) are typically
higher at 3 Tesla although the overall image quality is not
necessarily affected by this change [118, 119].
Regarding the differentiation of acute versus chronic
infarction, the sole application of LGE imaging techniques
is limited in its diagnostic use. The presence of LGE can be
assessed as early as 1 h after infarction [120], but various
mechanisms and principles maintain the effect of LGE in
the infarct into its chronic stage [121]. Further differenti-
ation can be provided by the additional use of T2-weighted
oedema imaging. LGE imaging in the early stage of
myocardial infarction not only allows the assessment of
the extent of necrotic myocardium but also the possible
delineation of areas of microvascular obstruction (MO),
which, in addition to the overall infarct size, shows a
correlation with the patient’s outcome and degree of LV
remodelling [122, 123]. Although several studies evaluated
the degree of MO in acute myocardial infarction using early
and late gadolinium enhancement imaging, which tech-
nique has the better predictive value in terms of LV
remodelling remains somewhat controversial [124–126].
Fig. 8 Differentiation of transmural extent of myocardial infarction
using late gadolinium enhancement (LGE) imaging. While the left
image (a) demonstrates an almost transmural LGE consistent with
only minor residual viable tissue, the patient on the right (b) only
suffered from a smaller subendocardial myocardial infarction in the
RCA territory
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MR and CT imaging are emerging as the most promising
complementary imaging techniques in the primary diagno-
sis of CAD and for coronary atherosclerotic disease
detection. For the detection or exclusion of significant
CAD, both cardiac CT—including coronary calcium
screening and non-invasive coronary angiography—and
cardiac MR, applying stress function and stress perfusion
imaging, are becoming widely available and are increas-
ingly being applied in clinical routine. Owing to their high
negative predictive value, especially in combining two or
more of these applications, the presence of CAD can be
excluded with a high probability, if patients are selected
correctly. Today, invasive coronary catheterisation cannot
fully be replaced by these techniques, and this should not
be the primary goal of future investigations. The first goal
might be a reduction of diagnostic invasive catheterisation
without angioplastic intervention, by a combined and
carefully selected approach using cardiac CT and/or MRI.
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